TOP TIERMARKET NEWSWIRE
News & sentiment

CYTOMX THERAPEUTICS (CTMX) — News & AI sentiment

CYTOMX THERAPEUTICS (CTMX) news roundup. 1 story in the past week, 6 over 30 days. Average 30-day sentiment is 60/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $5K — net selling of $5K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 55/100
30d stories
6
avg sentiment 60/100
Insider net (90d)
$5K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

CTMX news in the last 24 hours, 7 days, 30 days and 90 days

How much CTMX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowCTMX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days155/100CTMX headlines →
Last 30 days660/100CTMX headlines →
Last 90 days1955.7/100CTMX headlines →

Latest stories on CTMX

3d ago
Sep 1
Sep 1
Aug 27
Aug 27
Aug 27
Aug 12
Aug 10
Aug 7
Aug 7
Aug 6
Aug 6
Aug 3
Jul 30
Jul 27
Jul 27
Jul 27
Jun 22
Jun 19
Jun 10
Jun 3
CytomX gains as licensing deal with Regeneron expands
Seeking Alpha67 · bullishproduct/pr
Jun 3
Jun 3
May 21
Open CTMX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →